Check out how Mayo Clinic Laboratories’ digital pathology initiative integrates digital infrastructure to deliver digital workflows for patients to improve overall care.
Liver Disease Testing - Mayo Clinic Laboratories
Mayo Clinic Laboratories offers the only comprehensive testing menu for liver disease developed by clinical experts that enables health care providers to determine the underlying cause and rule out other causes for the disease.
Our serum test is the first preeclampsia-specific test that can be used to stratify patients into low- or high-risk categories, indicating whether a patient is at risk for developing preeclampsia with severe features.
Frequently asked questions - Insights
Check out how chromosomal microarray testing at Mayo Clinic Laboratories can help optimize treatment for neurological tumors.
Ceramides are lipids associated with atherosclerotic plaque formation, hypertension, insulin resistance, and obesity. Mayo Clinic Laboratories’ testing quantifies ceramides, providing an early indicator to help physicians predict heart...
Learn how Mayo Clinic Laboratories testing for adrenal diseases can help physicians detect and classify adrenal disorders.
A Test in Focus Archives - Page 7 of 10 - Insights
Skip to Content MayoACCESS MayoLINK...
A Test in Focus Archives - Page 6 of 10 - Insights
Skip to Content MayoACCESS MayoLINK...
A Test in Focus Archives - Page 9 of 10 - Insights
Skip to Content MayoACCESS MayoLINK...
A Test in Focus Archives - Page 8 of 10 - Insights
Skip to Content MayoACCESS MayoLINK...
At Mayo Clinic Laboratories, familial variant analysis can clarify genetic variants in family members when a variant of interest has been previously identified.
Find out more about our cost-effective immunoassay panel, which uses oral fluid testing to support addiction treatment and pain management.
Learn more about Mayo Clinic Laboratories’ testing to identify and monitor nicotine use as part of a patient’s nicotine-use cessation treatment plan, before anesthesia/surgery, or as part of insurance policy assessments.
Precision pain management - Insights
Our liquid chromatography-tandem mass spectrometry, high-resolution accurate mass (LC-MS/MS HRAM) screens, and confirmatory testing for controlled substances are available based on the needs of your patients.
New gene panel enhances brain tumor profiles - Insights
Cristiane (Cris) Ida, M.D., explains how Mayo Clinic Laboratories' updated neuro-oncology gene panel provides more clinically relevant information for managing adult and pediatric brain tumors.
Our suite of preeclampsia, prenatal, breast and gynecological cancer, and other testing has been developed in collaboration with clinical leaders in a variety of women’s health specialties to provide accurate, actionable results.
New tests launched in October - Insights
In October 2022, Mayo Clinic Laboratories announced thirty new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New tests launched in March - Insights
In March 2022, Mayo Clinic Laboratories announced eighteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Improving diagnosis and treatment of Helicobacter pylori - Insights
Mayo Clinic Laboratories now offers a noninvasive approach for the molecular detection of H. pylori, with results that include prediction of clarithromycin resistance delivered within 24 hours.
Communiqué Archives - Page 2 of 4 - Insights
Skip to Content MayoACCESS MayoLINK...
Communiqué Archives - Page 3 of 4 - Insights
Skip to Content MayoACCESS MayoLINK...
Testing Archives - Page 2 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Testing Archives - Page 3 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Testing Archives - Page 4 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Our experts discuss the latest from Mayo Clinic Laboratories, so you can stay up to date on the most advanced diagnostics and newly developed tests. Note: Podcasts will not play back on Internet Explorer. Please use an alternative web...
Mitochondrial Disease [Test in Focus] - Insights
Linda Hasadsri, M.D., Ph.D., explains how Mayo Clinic Laboratories’ inclusive approach to mitochondrial disease testing expedites diagnosis. Using innovative methodologies like custom reagents and droplet digital PCR enables precision...
Carrier Screening [Test in Focus] - Insights
Michelle Kluge, M.S., CGC, explains how Mayo Clinic Laboratories’ CYPZ assay provides accurate testing for congenital adrenal hyperplasia. Using an in-depth methodology that incorporates Sanger sequencing, MCL can provide clear answers for...
Myasthenia Gravis Testing - Mayo Clinic Laboratories
Our diagnostic algorithms consist of tests that are always performed, and then additional testing is performed depending on the initial results.
Neuro-Oncology Testing - Mayo Clinic Laboratories
At Mayo Clinic, we offer a comprehensive approach to neuro-oncology testing that focuses on the best outcomes for the patient
Peripheral neuropathy - Insights
Learn about our peripheral neuropathy testing to identify autoimmune and genetic causes of the condition.
Testing for systemic lupus erythematosus (SLE) and related antiphospholipid syndrome (APS) at Mayo Clinic Laboratories is performed by experienced laboratory scientists and testing experts with decades of experience diagnosing autoimmune...
See how our innovative evaluations detect multiple sclerosis with increased sensitivity to put patients on the correct diagnostic pathway.
Hereditary Alzheimer's disease and dementia - Insights
Learn about our genetic testing for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), frontotemporal dementia, and CADASIL.
Hereditary movement disorders - Insights
Learn about our advanced genetic testing for hereditary movement disorders, including ataxias, Huntington’s disease, and Parkinson’s disease.
Improving outcomes through comprehensive controlled substance monitoring - Insights
Controlled substance testing options vary in the details they provide about patient drug use, painting an incomplete picture of usage patterns that can hinder accurate prescription monitoring and treatment outcomes. However, a new...
Yuma Regional Medical Center: Strategic expansion to serve a growing community - Insights
Faced with a population increase and the need to expand both laboratory testing capacity and capabilities, Yuma Regional Medical Center leaned into its relationship with Mayo Clinic Laboratories to gain insights to strengthen community...
Cayuga Medical Center: Building a world-class lab that drives revenue - Insights
Cayuga Medical Center sought to challenge the narrative that a hospital’s lab is an expensive liability by positioning themselves as the laboratory of choice in their area.
Myasthenia Gravis [Test in Focus] - Insights
Christopher Klein, M.D., discusses Mayo Clinic’s updated myasthenia gravis and Lambert-Eaton syndrome testing approach. Automatic reflex to second-line testing saves time and increases sensitivity and specificity to confirm diagnosis in...
Mayo Clinic Labs @Work: Sherri Hawkins - Insights
With nearly 30 years at Mayo Clinic, Sherri Hawkins has served in a wide range of laboratory-related roles. Beginning as a laboratorian on the bench and now serving as Group Purchasing Organization (GPO) manager, Sherri has been able to...
Cutting-edge lab work cracks a medical mystery: Kenneth Hobby - Insights
Kenneth Hobby assumed his fever, fatigue, and aching pains in May 2018 were from another bout of malaria. He was on one of his frequent visits to Zambia in southern Africa, where the mosquito-borne parasite is common. But anti-malaria drugs...
Diagnostic expertise leads to recovery from rare cancer: Alison O'Neill - Insights
After what looked like a blemish turned out to be angiosarcoma, a rare, life-threatening cancer of the blood vessels, Alison O'Neill was put on an aggressive treatment plan and regenerative approach to healing made possible by the...
MCL @Work: Joune Twist - Insights
Joune Twist has always embraced her natural interest for learning new information and improving processes. In 2019, her curiosity and previous work led her to join Mayo Clinic’s Neuroimmunology Lab. As a medical laboratory scientist, Joune...
Mayo Clinic Laboratories has launched a first-in-the-U.S. autoimmune test of the Kelchlike protein 11 antibody, or KLHL11, which is used to detect autoimmune disease associated with testicular cancer.
West Nile virus [Test in Focus] - Insights
Bobbi Pritt, M.D., discusses how Mayo Clinic Labs’ updated PCR assay for West Nile virus provides increased sensitivity to detect virus RNA in multiple sources, identifies two virus lineages, and confirms diagnosis.
Including comprehensive panels and medication targeted assays, Mayo Clinic Laboratories pharmacogenomic testing focuses on clinically actionable genes and enables the detection of more alleles than other testing.
Hot Topic Archives - Page 5 of 5 - Insights
Skip to Content MayoACCESS MayoLINK...
Learn how our testing identifies genetic and autoimmune causes of epilepsy. Accurate diagnosis helps physicians identify potential treatment options.
Hot Topic Archives - Page 4 of 5 - Insights
Skip to Content MayoACCESS MayoLINK...
Learn more about educational offerings available to primary clients of Mayo Clinic Laboratories.
On Demand Education organized by MLS credit categories.